Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

2.03
Delayed Data
As of Feb 05
 +0.02 / +1.00%
Today’s Change
0.36
Today|||52-Week Range
4.37
-38.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues729.1K2.6M55.8K46.9K
 
 
 
 
 
Cost of Goods Sold23.0K37.5K34.2K30.7K
 
 
 
 
 
Depreciation And Amortization1.7K1.8K1.4K1.4K
 
 
 
 
 
 
Operating ExpensesGross Income704.4K2.5M20.2K14.7K
 
 
 
 
 
General Expenses1.4M915.6K5.3M10.0M
 
 
 
 
 
Research And Development737.3K557.5K482.7K5.2M
 
 
 
 
 
Total Operating Expenses1.4M954.9K5.3M10.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-710.9K1.6M-5.3M-10.0M
 
 
 
 
 
Extraordinary Credit189.6K0.000.000.00
 
 
Interest Expense On Debt70.7K52.5K56.9K29.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-592.0K1.6M-5.3M-10.0M
 
 
 
 
 
Income Taxes-99.2K0.000.000.00
 
 
Net Income-492.8K1.6M-5.3M-10.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS35.9M36.3M37.2M39.1M
 
 
 
 
 
Shares To Calculate EPS Diluted35.9M38.3M37.2M39.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02$0.04-$0.14-$0.26
 
 
 
 
 
EPS Diluted-$0.01$0.04-$0.14-$0.26